Main > NEUROLOGY. > Multiple Sclerosis>Walking Improve. > Treatment > Co: USA. B. Dalfampridine ER Tab.

---

Co: USA. B. Dalfampridine ER Tab.'s subsections
(*) EU Approval Date: 2017. 05.24
Company/Licensee
Company/Licensor
EU Patent>Expiration: 2025
EU Patent>No.
Press Release Web-Site
TradeMark
UpDate: 2017. 05.25.

Co: USA. B. Dalfampridine ER Tab.'s products
This section has no products